OncologyCIMAvax-EGF: Cuba's Innovative Approach to Lung Cancer Immunotherapy
An overview of the therapeutic vaccine developed by Cuba's Center of Molecular Immunology, its mechanism of action targeting the EGF pathway, and its role in the international landscape of cancer immunotherapy.





